Ratings Sally Beauty Holdings, Inc. BOERSE MUENCHEN

Equities

S7V

US79546E1047

Real-time BOERSE MUENCHEN Other stock markets 15:13:07 2024-07-03 EDT			5-day change	1st Jan Change
10.4 ^EUR	0.00%		+5.05%	-16.13%

07-01	Sally Beauty Holdings, Inc.(NYSE:SBH) dropped from Russell 3000 Growth Index	CI
07-01	Sally Beauty Holdings, Inc.(NYSE:SBH) dropped from Russell Small Cap Comp Growth Index	CI

Summary

The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The stock, which is currently worth 2024 to 0.55 times its sales, is clearly overvalued in comparison with peers.
The company has a low valuation given the cash flows generated by its activity.
Considering the small differences between the analysts' various estimates, the group's business visibility is good.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
For the last few months, analysts have been revising downwards their earnings forecast.
Over the past four months, analysts' average price target has been revised downwards significantly.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Other Specialty Retailers

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
SALLY BEAUTY HOLDINGS, INC.	-16.13%	1.15B		-
TRACTOR SUPPLY COMPANY	+21.68%	28.68B		A-
AVOLTA AG	+7.07%	5.73B		B-
JARIR MARKETING COMPANY	-18.87%	4.04B		C
JUMBO S.A.	+7.88%	3.9B		C+
UPBOUND GROUP, INC.	-11.69%	1.65B		C+
GRUPO GIGANTE, S. A. B. DE C. V.	-2.61%	1.63B	-	B-
WINMARK CORPORATION	-15.54%	1.21B	-	C
LESLIE'S, INC.	-47.32%	695M		D+
MATAS A/S	+3.12%	647M		B

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes